The exit in CG/B is due to valuation - even with a revised target, there appears to be less than 20% upside over the year.
The exit in Top 20 follows a very disappointing Q4 and outlook. While I expect that the company will overcome these challenges and improve its operations, I think it could take time. The stock has bounced nicely in the past few days - patience rewarded for not blowing the stock out immediately. Our buy is a turnaround story that could yield quicker results. I get a 43% return to my one-year expected price on the buy, while the sell offers less than 30%.
